LabCorp’s Acquisition of MEDTOX Clears Antitrust Approval

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 13, 2012-- Laboratory Corporation of America® Holdings (NYSE: LH) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to the

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 2, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

LabCorp to Offer Age-Based Guideline Initiative for Cervical Cancer and STD Screening

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 14, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today the launch of an innovative age-based test protocol that aids physicians when ordering cervical cancer and sexually transmitted disease (STD) screening tests.

LabCorp Announces Agreement to Acquire MEDTOX Scientific

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 4, 2012-- Laboratory Corporation of America ® Holdings (NYSE: LH) and MEDTOX Scientific, Inc. (NASDAQ: MTOX), a provider of high quality specialized laboratory testing services and on-site/point-of-collection testing (POCT) devices, today announced that they

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--May. 8, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas, NV.

LabCorp(R) to Webcast Its Annual Meeting of Stockholders

BURLINGTON, N.C., Apr 27, 2012 (BUSINESS WIRE) --Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced that its Annual Meeting of Stockholders will be webcast live beginning May 1, 2012 at 9:00 a.m. Eastern Daylight Time via the Company Web site at www.labcorp.com

Laboratory Corporation of America(R) Holdings
Announces 2012 First Quarter Results

Revenue Growth Drives Q1 Diluted EPS of $1.63 and Adjusted EPS Excluding Amortization of $1.74, up 14.5% BURLINGTON, N.C., Apr 19, 2012 (BUSINESS WIRE) --Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced results for the quarter ended March 31, 2012.

Conversion Right Triggered for LabCorp(EQNX::rightsinglequotation)s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Apr 02, 2012 (BUSINESS WIRE) --Laboratory Corporation of America (EQNX::registered) Holdings (LabCorp (EQNX::registered) ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 2, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 13, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that for the period of March 12, 2012 to September 11, 2012 , its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the